Molecular Cancer Therapeutics

Molecular Cancer Therapeutics Journal

Publication venue for

Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy. 20:1295-1304. 2021
Response of CNS melanoma to 4-demethyl-4-cholestrylcarbonylpenclomedine (DM-CHOC-PEN) and cell death. 12. 2013

International Standard Serial Number (ISSN)

1535-7163